Record Information |
---|
Version | 5.0 |
---|
Status | Predicted |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-07-07 22:43:02 UTC |
---|
HMDB ID | HMDB0000918 |
---|
Secondary Accession Numbers | - HMDB0005191
- HMDB00918
- HMDB05191
|
---|
Metabolite Identification |
---|
Common Name | CE(18:1) |
---|
Description | Cholesteryl oleate is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). Cholesteryl esters, formed by the esterification of cholesterol with long-chain fatty acids, on one hand, are the means by which cholesterol is transported through the blood by lipoproteins, on the other, the way cholesterol itself can be accumulated in the cells. (PMID: 15939411 ). |
---|
Structure | CCCCCCCC\C=C/CCCCCCCC(=O)O[C@H]1CC[C@]2(C)C3CC[C@]4(C)C(CCC4C3CC=C2C1)[C@H](C)CCCC(C)C InChI=1S/C45H78O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-43(46)47-38-30-32-44(5)37(34-38)26-27-39-41-29-28-40(36(4)24-22-23-35(2)3)45(41,6)33-31-42(39)44/h14-15,26,35-36,38-42H,7-13,16-25,27-34H2,1-6H3/b15-14-/t36-,38+,39?,40?,41?,42?,44+,45-/m1/s1 |
---|
Synonyms | Value | Source |
---|
1-Oleoyl-cholesterol | HMDB | 18:1(9Z) Cholesterol ester | HMDB | 3beta-Hydroxy-5-cholestene 3-oleate | HMDB | 5-Cholesten-3b-ol 3-oleate | HMDB | CE(18:1) | HMDB | CE(18:1/0:0) | HMDB | CE(18:1n9/0:0) | HMDB | CE(18:1W9/0:0) | HMDB | Cholest-5-en-3-beta-yl oleate | HMDB | Cholest-5-en-3-ol (3b)-(Z)-9-octadecenoate | HMDB | Cholest-5-en-3-ol (3b)-(Z)-9-octadecenoic acid | HMDB | Cholest-5-en-3b-yl | HMDB | Cholesterol 1-(9Z-octadecenoate | HMDB | Cholesterol 1-(9Z-octadecenoate) | HMDB | Cholesterol 1-(9Z-octadecenoic acid | HMDB | Cholesterol 1-(9Z-octadecenoic acid) | HMDB | Cholesterol 3beta-oleate | HMDB | Cholesterol ester(18:1) | HMDB | Cholesterol ester(18:1/0:0) | HMDB | Cholesterol ester(18:1n9/0:0) | HMDB | Cholesterol ester(18:1W9/0:0) | HMDB | Cholesteroyl-oleate | HMDB | Cholesteryl 1-oleoate | HMDB | Cholesteryl 1-oleoic acid | HMDB | Cholesteryl cis-9-octadecenoate | HMDB | Cholesteryl cis-9-octadecenoic acid | HMDB | Cholesteryl oleate | HMDB | Cholesteryl oleate-9,10-3H | HMDB | Cholesteryl oleate-9,10-t2 | HMDB | Cholesteryl oleic ester | HMDB | Cholesteryl [9,10-3H]oleate | HMDB | Cholesteryl-beta-D-glucoside | HMDB | Cholesteryl-beta-delta-glucoside | HMDB | Oleic acid cholesteryl ester | HMDB | Oleoylcholesterol | HMDB | Cholesteryl 1-(9Z-octadecenoate) | HMDB | Cholesterol 1-oleoic acid | HMDB | Cholesteryl 1-(9Z-octadecenoic acid) | HMDB | Cholesterol 1-oleoate | HMDB | 1-(9Z-Octadecenoyl)-cholesterol | HMDB | CE(18:1(9Z)) | Lipid Annotator |
|
---|
Chemical Formula | C45H78O2 |
---|
Average Molecular Weight | 651.117 |
---|
Monoisotopic Molecular Weight | 650.600181752 |
---|
IUPAC Name | (2R,5S,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (9Z)-octadec-9-enoate |
---|
Traditional Name | (2R,5S,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (9Z)-octadec-9-enoate |
---|
CAS Registry Number | 303-43-5 |
---|
SMILES | CCCCCCCC\C=C/CCCCCCCC(=O)O[C@H]1CC[C@]2(C)C3CC[C@]4(C)C(CCC4C3CC=C2C1)[C@H](C)CCCC(C)C |
---|
InChI Identifier | InChI=1S/C45H78O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-43(46)47-38-30-32-44(5)37(34-38)26-27-39-41-29-28-40(36(4)24-22-23-35(2)3)45(41,6)33-31-42(39)44/h14-15,26,35-36,38-42H,7-13,16-25,27-34H2,1-6H3/b15-14-/t36-,38+,39?,40?,41?,42?,44+,45-/m1/s1 |
---|
InChI Key | RJECHNNFRHZQKU-DVPYOPPASA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Steroid esters |
---|
Direct Parent | Cholesteryl esters |
---|
Alternative Parents | |
---|
Substituents | - Cholesteryl ester
- Cholesterol
- Cholestane-skeleton
- Delta-5-steroid
- Carboxylic acid ester
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - CE(18:1) GC-MS (Non-derivatized) - 70eV, Positive | splash10-00ku-5359047000-b0786012be7d0cac7c83 | 2017-09-14 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CE(18:1) 10V, Negative-QTOF | splash10-0002-0024009000-dccc63058b1b8d7cddc9 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CE(18:1) 20V, Negative-QTOF | splash10-000i-0049003000-755458c70f1eed13712d | 2017-09-20 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CE(18:1) 40V, Negative-QTOF | splash10-00ku-2029000000-170f3ca0c9bd97272276 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CE(18:1) 10V, Positive-QTOF | splash10-0uxr-1165029000-1ce7930cf3150163fd8d | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CE(18:1) 20V, Positive-QTOF | splash10-01bi-5379031000-e18668a49f8d8d48ee71 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CE(18:1) 40V, Positive-QTOF | splash10-0629-6369130000-9782f8bcc5e881bea861 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CE(18:1) 10V, Positive-QTOF | splash10-0gc0-4039026000-807a77313ffb119421bd | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CE(18:1) 20V, Positive-QTOF | splash10-0a4l-9110000000-d78ed0ea6e721a187f92 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CE(18:1) 40V, Positive-QTOF | splash10-052f-9100000000-4804d89b0b9e262fabb9 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CE(18:1) 10V, Negative-QTOF | splash10-0002-0020009000-d95a9dce4154675002c9 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CE(18:1) 20V, Negative-QTOF | splash10-0002-0013009000-ecd587e023698b4f55cd | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CE(18:1) 40V, Negative-QTOF | splash10-0btj-8767697000-e635b5469ba14e38a163 | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|
General References | - Tall A, Granot E, Brocia R, Tabas I, Hesler C, Williams K, Denke M: Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest. 1987 Apr;79(4):1217-25. [PubMed:3558822 ]
- Busch SJ, Stuart WD, Hug B, Mao SJ, Harmony JA: Plasma cholesteryl ester-triglyceride transfer protein. The catalytic domain is a low molecular weight proteolipid. J Biol Chem. 1987 Dec 25;262(36):17563-71. [PubMed:3693366 ]
- Adam O, Wolfram G, Zollner N: Influence of dietary linoleic acid intake with different fat intakes on arachidonic acid concentrations in plasma and platelet lipids and eicosanoid biosynthesis in female volunteers. Ann Nutr Metab. 2003;47(1):31-6. [PubMed:12624485 ]
- Hui SP, Murai T, Yoshimura T, Chiba H, Nagasaka H, Kurosawa T: Improved HPLC assay for lipid peroxides in human plasma using the internal standard of hydroperoxide. Lipids. 2005 May;40(5):515-22. [PubMed:16094862 ]
- Benoist F, Lau P, McDonnell M, Doelle H, Milne R, McPherson R: Cholesteryl ester transfer protein mediates selective uptake of high density lipoprotein cholesteryl esters by human adipose tissue. J Biol Chem. 1997 Sep 19;272(38):23572-7. [PubMed:9295295 ]
- Sklar LA, Craig IF, Pownall HJ: Induced circular dichroism of incorporated fluorescent cholesteryl esters and polar lipids as a probe of human serum low density lipoprotein structure and melting. J Biol Chem. 1981 May 10;256(9):4286-92. [PubMed:7217083 ]
- Seo T, Qi K, Chang C, Liu Y, Worgall TS, Ramakrishnan R, Deckelbaum RJ: Saturated fat-rich diet enhances selective uptake of LDL cholesteryl esters in the arterial wall. J Clin Invest. 2005 Aug;115(8):2214-22. Epub 2005 Jul 21. [PubMed:16041409 ]
- Ceryak S, Bouscarel B, Malavolti M, Robins SJ, Caslow KL, Fromm H: Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters. Atherosclerosis. 2000 Nov;153(1):59-67. [PubMed:11058700 ]
- Gwynne JT, Mahaffee DD: Rat adrenal uptake and metabolism of high density lipoprotein cholesteryl ester. J Biol Chem. 1989 May 15;264(14):8141-50. [PubMed:2542267 ]
- Albers JJ, Marcovina SM, Christenson RH: Lecithin cholesterol acyltransferase in human cerebrospinal fluid: reduced level in patients with multiple sclerosis and evidence of direct synthesis in the brain. Int J Clin Lab Res. 1992;22(3):169-72. [PubMed:1387817 ]
- Matsuda K: ACAT inhibitors as antiatherosclerotic agents: compounds and mechanisms. Med Res Rev. 1994 May;14(3):271-305. [PubMed:8007738 ]
- Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M: Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res. 1997 Oct;38(10):2012-22. [PubMed:9374124 ]
- Kuipers F, Nagelkerke JF, Bakkeren H, Havinga R, Van Berkel TJ, Vonk RJ: Processing of cholesteryl ester from low-density lipoproteins in the rat. Hepatic metabolism and biliary secretion after uptake by different hepatic cell types. Biochem J. 1989 Feb 1;257(3):699-704. [PubMed:2930479 ]
- Oliveira HC, Nilausen K, Meinertz H, Quintao EC: Cholesteryl esters in lymph chylomicrons: contribution from high density lipoprotein transferred from plasma into intestinal lymph. J Lipid Res. 1993 Oct;34(10):1729-36. [PubMed:8245723 ]
- Tosi MR, Tugnoli V: Cholesteryl esters in malignancy. Clin Chim Acta. 2005 Sep;359(1-2):27-45. [PubMed:15939411 ]
|
---|